237 related articles for article (PubMed ID: 30450559)
1. The 3D isodose structure-based method for clinical dose distributions comparison in pretreatment patient-QA.
Tamborra P; Martinucci E; Massafra R; Bettiol M; Capomolla C; Zagari A; Didonna V
Med Phys; 2019 Feb; 46(2):426-436. PubMed ID: 30450559
[TBL] [Abstract][Full Text] [Related]
2. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
5. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
6. A clinically relevant IMRT QA workflow: Design and validation.
Stambaugh C; Ezzell G
Med Phys; 2018 Apr; 45(4):1391-1399. PubMed ID: 29481698
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of DVH-based treatment plan verification in addition to gamma passing rates for head and neck IMRT.
Visser R; Wauben DJ; de Groot M; Steenbakkers RJ; Bijl HP; Godart J; van't Veld AA; Langendijk JA; Korevaar EW
Radiother Oncol; 2014 Sep; 112(3):389-95. PubMed ID: 25154319
[TBL] [Abstract][Full Text] [Related]
9. Isodoses-a set theory-based patient-specific QA measure to compare planned and delivered isodose distributions in photon radiotherapy.
Baran M; Tabor Z; Kabat D; Tulik M; Jeleń K; Rzecki K; Forostianyi B; Bałabuszek K; Koziarski R; Waligórski MPR
Strahlenther Onkol; 2022 Sep; 198(9):849-861. PubMed ID: 35732919
[TBL] [Abstract][Full Text] [Related]
10. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
[TBL] [Abstract][Full Text] [Related]
11. Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.
Chan MF; Li J; Schupak K; Burman C
Technol Cancer Res Treat; 2014 Feb; 13(1):57-67. PubMed ID: 23819494
[TBL] [Abstract][Full Text] [Related]
12. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
13. Error detection model developed using a multi-task convolutional neural network in patient-specific quality assurance for volumetric-modulated arc therapy.
Kimura Y; Kadoya N; Oku Y; Kajikawa T; Tomori S; Jingu K
Med Phys; 2021 Sep; 48(9):4769-4783. PubMed ID: 34101848
[TBL] [Abstract][Full Text] [Related]
14. Technical Note: Three-dimensional QA of simultaneous integrated boost radiotherapy treatments by a dose-volume histogram methodology and its comparison with 3D gamma results.
Acurio ESR; Lizar JC; Arruda GV; Pavoni JF
Med Phys; 2021 Jun; 48(6):3208-3215. PubMed ID: 33768577
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gamma index based on dosimetric error and clinically relevant dose-volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy.
Kaneko A; Sumida I; Mizuno H; Isohashi F; Suzuki O; Seo Y; Otani K; Tamari K; Ogawa K
Radiat Oncol; 2019 Feb; 14(1):36. PubMed ID: 30808377
[TBL] [Abstract][Full Text] [Related]
16. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
Zhen H; Nelms BE; Tome WA
Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant quality assurance for intensity modulated radiotherapy plans: gamma maps and DVH-based evaluation.
Caivano R; Califano G; Fiorentino A; Cozzolino M; Oliviero C; Pedicini P; Clemente S; Chiumento C; Fusco V
Cancer Invest; 2014 Mar; 32(3):85-91. PubMed ID: 24499109
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of one algorithm used to modify a planned DVH with data from actual dose delivery.
Ma T; Podgorsak MB; Kumaraswamy LK
J Appl Clin Med Phys; 2016 Sep; 17(5):273-282. PubMed ID: 27685140
[TBL] [Abstract][Full Text] [Related]
19. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
20. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]